University of Washington Regional Epilepsy Center at Harborview Medical Center

Publications of Faculty 1999-2002

1. Anderson GD, Gidal BE, Messenheimer JA, Gilliam FG. Time course of lamotrigine-induction: impact of stepwise withdrawal of carbamazepine or phenytoin. Epilepsy Research 2002;49:211-217.

2. Anderson GD, Kim H, Warner MH. Impact of taking antiepileptic drugs at school in a group of children and adolescents. Epilepsy and Behavior, 2000; 1:17-21.

3. Anderson GD, Lin Y-X, Temkin NR, Fischer JH, Winn HR. Incidence of intravenous site reactions in neurotraumapatients receiving valproate or phenytoin. Annals of Pharmacotherapy, 2000; 34:697-702.

4. Anderson GD, Miller JW. Newer antiepileptic drugs: Their collective role and defining characteristics Formulary, 2001;36:114-135.

5. Anderson GD, Miller JW: Benzodiazepine pharmacology and pharmacokinetic properties. In Levy R, Mattson R,Meldrum B, and Perucca, E: Antiepileptic Drugs, Fifth Edition, Lippincott, Williams & Wilkins, Philadelphia, PA, 2002.

6. Anderson GD, Rosito G, Mohustsy MA, Elmer GW. Interaction potential of soy extract and panax ginseng. J Clin Pharmacol 2003;43:643-648.

7. Anderson GD, Temkin NR, Chandler WL, Winn HR. Effect of valproate on hemostatic function in patients with traumatic brain injury. Epilepsy Research in press

8. Anderson GD. Sex differences in drug metabolism: Cytochrome P450 and UDP glucuronoysl tranasferase, J Gender Specific Medicine 2001;5:25-33

9. Anderson GD. Children vs. Adults: Pharmacokinetic and adverse effect differences. Epilepsia. 2002;43 Suppl 3:53-59.

10. Aoki F. Fetz EE, Shupe L, Lettich E, Ojemann GA: Increased gamma-range activity in human sensorimotor cortex during performance of visuomotor tasks. EEG Clin. Neurophysiol., 110:524-537, 1998.

11. Bombardier C, Temkin N, Machamer J, Dikmen S. The natural history of drinking and alcohol-related problems after traumatic brain injury. Arch Phys Med Rehabil 84(2): 185-191, 2003.

12. Chan L, Doctor J, Temkin N, MacLehose RF, Esselman P, Bell K, Dikmen S. Insurance type & discharge disposition from acute care following traumatic brain injury. Arch Phys Med Rehabil 82(9):1151-1154,2001.

13. Chatrian, G.E., Tsai, M.L., Temkin, N.R, Holmes, M.D., Pauri, F., Ojemann, G.A.: Role of the ECoG in Tailored Temporal Resection: The University of Washington Experience. Electroencephalogr Clin Neurophysiol Suppl. 48:24-43, 1999.

14. Cherner M, Temkin N, Machamer J, Dikmen SS: Utility of a composite measure to detect problematic alcohol use inpersons with traumatic brain injury. Arch Phys Med Rehabil 82(6):780-786, 2001.

15. Corina D, McBurney S, Dodrill C, Hinshaw K, Brinkley J, Ojemann G: Functional roles of Broca’s area and SMG: Evidence from cortical stimulation mapping in a deaf singer. NeuroImage, 10:570-581, 1999.

16. D’Ambrosio R, Gordon D.S., and Winn H.R.: Differential roles of KIR channel and Na+/K+-pump in the regulation of extracellular K+ accumulation in rat hippocampus. Journal of Neurophysiology (2002) Vol 87: 87-102.

17. D’Ambrosio R., Maris D.O., Grady S.M., Winn H.R., and Janigro D.: Impaired K+ homeostasisand altered electrophysiological properties of post-traumatic hippocampalglia. Journal of Neuroscience (1999), 19(18): 8152-62.

18. Dikmen S, Machamer J, Temkin N: Mild head injury: facts and artifacts. J Clin Exp Neuropsychol 23(6): 729-738, 2001

19. Dikmen SS, Heaton RK, Grant I, Temkin NR: Test-retest reliability and practice effects of expanded Halstead-Reitan Neuropsychological Test Battery. J Int Neuropsycholy Soc 5:346-356, 1999.

20. Dikmen SS, Machamer J, Miller B, Doctor J, Temkin N. Functional Status Examination: A new instrument for assessing outcome in traumatic braininjury. J Neurotrauma18(2): 127-140, 2001.

21. Dikmen SS, Machamer JE, Powell JM, Temkin NR. Outcome 3 to 5 years following moderate to severe traumatic brain injury. Arch Phys Med Rehabil (in press, 2003).

22. Dikmen SS, Machamer JE, Winn HR, Anderson GD, Temkin NR. Neuropsychological effects of valproate in persons with traumatic brain injury: a randomized trial. Neurology, 2000;54:895-902.

23. Dodrill CB, Arnett JL, Deaton R, Lenz GT, Sommerville KW. Tiagabine vs. phenytoin and carbamazepine as add-on therapies: effects on abilities,adjustment, and mood. Epilepsy Research, 2000;42:123-132.

24. Dodrill CB, Arnett JL, Hayes AG, Garofalo EA, Greeley CA, Greiner MJ, Pierce MW. Cognitive abilities and adjustment with gabapentin: results of a multisite study. Epilepsy Research1999;35:109-121.

25. Dodrill CB, Batzel LW. Psychosocial assessment. In H Meinardi (Ed.),Handbook of Clinical Neurology, vol 72 (28): The Epilepsies, Part I. Amsterdam: Elsevier, 1999, pp 407-414.

26. Dodrill CB, Holmes MD. Psychological and neuropsychological evaluation of the patient with non-epileptic seizures. In JR Gates and AJ Rowan (Eds.), Non-epileptic seizures (2nd ed.). Boston: Butterworth Heineman, 2000, 169-181.

27. Dodrill CB, Morris GL. Effects of vagal nerve stimulation upon cognition and quality of life in epilepsy. Epilepsy and Behavior 2001;2:46-53.

28. Dodrill CB. Myths of neuropsychology: further considerations. The Clinical Neuropsychologist 1999;13:562-572.

29. Dodril lCB. Neuropsychological and quality of life outcomes with vagal nerve stimulation in epilepsy. In: D Naritoku (Ed.), Vagus Nerve Stimulation: Neurobiology and Clinical Use. Amsterdam: Elsevier, in press.

30. Dodrill CB. Overview: Presurgical neuropsychological evaluation. In H Luders, Y Comair, Epilepsy Surgery (2nd ed.). Philadelphia: Lippincott Williams and Wilkins, 2001, pp. 475-480.

31. Dodrill CB. Progressive cognitive decline in adolescents and adults with epilepsy. In T Sutula and A Pitkanen and (Eds.), Do seizures damage the brain? (Progress in Brain Research , vol.135). Amsterdam: Elsevier, 2002, pp.399-407.

32. Doherty M, Simon E, Sotero de Menzies, M, Kuratani J, Saneto R, Holmes M, Farrell D,Watson N, Dodrill C, Miller JW. When Might Hemispheric Favoring of Epileptiform Discharges Begin? Seizure. 2003 Dec;12(8):595-8.

33. Doherty M, Walting P, Morita D, Peterson R, Miller JW, Holmes M, Watson N. Do Focal Slowing and Epileptiform Discharges Favor the Left Hemisphere? Epilepsia 43(12):1593-1595, 2002.

34. Doherty M, Wilensky, A, Holmes M.D., Lewis, D, Rae J, Cohn G. Singing Seizures. Neurology 59(9):1435-1438; 2002.

35. Doherty MJ., Walting PJ., Morita DC, Peterson RA., Miller JW, Holmes MD, Watson NF: Do Focal EEG Slowing and Epileptiform Discharges Favor the Left Hemisphere?, Epilepsia 43:1593-1595, 2002.

36. Donevan SD, White HS, Anderson GD, Rho JM. Voltage-dependent block of n-methyl-d-aspartate receptors by the novel anticonvulsant dibenzylamine, a bioactive constituent of l-( )-[[beta]]-hydroxybutyrate. Epilepsia 2003;44:1274-1279.

37. Douglas, JG, Silbergeld, DL, Winn, H.R, Laramore, GE: Gamma Knife Stereotactic Radiosurgical Boost for Patients Treated Primarily with Neutron Radiotherapy for Salivary Gland Neoplasms. J Neurosurg, in press.

38. Drane, D. L., & Meador, K. J. (2002). Cognitive and behavioral effects of antiepileptic drugs. Epilepsy and Behavior, 3 (suppl. 5), S49-S53.

39 Drane, D. L., & Meador, K. J. (2002). Cognitive toxicity of antiepileptic drugs. In O. Devinsky & L. E. Westbrook (Eds.). Epilepsy and Developmental Disorders (pp. 311-330). Boston, MA: Butterworth-Heinemann.

40. Drane DL, Yuspeh RL, Huthwaite JS, Klingler LK. Demographic characteristics and normative observations for derived-trail making test indices. Neuropsychiatry Neuropsychol Behav Neurol. 2002 Mar;15(1):39-43.

41. Duntley SP, Kim A, Silbergeld DL, Miller JW: The occurrence of the mu rhythm during REM sleep. Clinical Neurophysiology, 112(3):528-31, 2001.

42. Eells, JB, Clough, RW, Miller, JW, Jobe, PC, Browning, RA: FOS Expression and2-deoxyglucose uptake following seizures in developing genetically epilepsy-prone rats, Brain Res. Bull., 52:379-389, 2000.

43. Englund, C, Silbergeld D, Alvord EC, Small R, Hevner, RF. A 24 year-old woman with bifrontal headaches. Brain Pathol,in press.

44. Ethell BT, Anderson GD, Burchell B. The effect of valproic acid on drug and steroid glucuronidation by expressed human UDP-glucuronosyltransferases. Biochem Pharmacol 2003;65:1141-1449.

45. Faught E, Ayala R, Montouris GG, Leppik IE,and the Zonisamide 922 Trial Group. Randomized controlled trial of of zonisamide for the treatment of refractory partial-onset seizures. Neurology 2001; 57:1774-1779.

46. Fraser RT, Thorbecke R, Koch-Stoecker S, Dodrill CB. A perspective on psychosocial intervention and outcome around epilepsy surgery. In M Pfafflin, RT Fraser, R Thorbecke, U Specht & P Wolf (Eds.), Comprehensive care for people with epilepsy. John Libbey & Co., 2001, pp. 99-112.

47. Fraser RT. Employment for People with Epilepsy. To the Editor. Epilepsy Behavior. 2002 Apr;3(2):201-203.

48. Freeman,W., Rogers, L., Holmes, M., Silbergeld, DL.: Spatial Spectral Analysis of Human Electrocorticograms Including the Alpha and Gamma Bands. J Neuroscience Methods 15; 95(2):1111-21,2000.

49. Gardner JS, Blough D, Drinkard C, Shatin D, Anderson GD, Graham D, Alderfer R. Tramadol and seizures: study in a managed care population, Pharmacotherapy 2000;20:1423-1431.

50. Gidal BE, Anderson GD, Shaw R, LanningA, Rutecki P. Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy. Epilepsy Research 2000;42:23-31.

51. Grant, GA, Farrell D, Silbergeld DL: Continuous somatosensory evoked potential monitoring during brain tumor resection. J Neurosurg, 2002 90:709-713.

52. Haltiner AM, Newell DW, Temkin NR, Dikmen SS, Winn HR. Side effects and mortality associated with use of phenytoin for early posttraumatic seizure prophylaxis. J Neurosurg 91(4):588-592, 1999.

53. Hanks RA, Temkin N, Machamer J, Dikmen SS. Emotional and behavioral adjustment after traumatic brain injury. Arch Phys Med Rehabil 80(9):991-997, 1999.

54. Heaton RK, Temkin N, Dikmen SS, Avitable N, Taylor M, Marcotte T, Grant I: Detecting Change: A comparison of three neuropsychological methods, using normal and clinical samples. Arch Clinical Neuropsychology 16:75-91,2001.

55. Heckbert SR, Kaplan RC, Starr JR, Psaty BM, Lin D, Furberg CD, LaCroix AZ, Anderson GD, Weiss NS. Risk of recurrent coronary heart disease in relation to recent starting of hormone replacement therapy, Arch Int Med 2001;161:1709-1713.

56. Hochman D.W., D’Ambrosio R., Janigro D., and Schwartzkroin P.A.: Extracellular chloride and the maintenance of spontaneous epileptiform activity in rat hippocampal slices. Journal of Neurophysiology (1999), 81:49-59.

57. Holmes MD, Born DE, Kutsy RL, Wilensky AJ, Ojemann GA, Ojemann LM. Outcome after surgery in patients with refractory temporal lobe epilepsy and normal MRI. Seizure 2000; 9:407-411.

58. Holmes MD, Dodrill CB, Bachtler S, Wilensky AJ, Ojemann LM, Miller JW. Evidence that emotional maladjustment is worse in men than in women with psychogenic nonepileptic seizures. Epilepsy & Behavior 2001; 2:568-573.

59. Holmes MD, Dodrill CB, Kutsy RL, Ojemann GA, Miller JW. Is the left cerebral hemisphere more prone to epileptogenesis than the right? Epileptic Disorders 2001;3:137-141.

60. Holmes MD, Kutsy RL, Ojemann GA, Wilensky AJ, Ojemann LM. Interictal, unifocal spikes in refractory extratemporal epilepsy predict ictal origin and postsurgical outcome. Clin Neurophysiol 2000;111:1802-1808.

61. Holmes MD, Wilensky AJ, Ojemann GA, Ojemann LM: Hippocampal or neocortical lesions on MRI do not necessarily indicate site of seizure onset in partial epilepsy. Ann. Neurol., 1999, 45:461-465.

62. Holmes MD, Wilensky AJ, Ojemann LM, Ojemann GA: Predicting outcome following reoperation for medically intractable epilepsy. Seizure, 8:103-106,1999.

63. Holmes, M., Born, D.B., Kutsy, R.L., Ojemann, G.A., Wilensky, A.J., Ojemann, L.M. Outcome After Surgery in Patients with Refractory Temporal Lobe Epilepsy and Normal MRI. Seizure 9: 407-411, 2000.

64. Holmes,M.D. Is epilepsy progressive? Epilepsy & Behavior 2:76-77, 2001.

65. Holmes,M.D., Dodrill, C., Batcheler, S., Wilensky, A., Ojemann, L., Miller, J. Evidence that Emotional Maladjustment is Worse in Men than in Women with Psychogenic Non-Epileptic Seizures. Epilepsy & Behavior 2, 568-573, 2001.

66. Holmes,M.D., Kutsy, R.L., Ojemann, G.A., Wilensky, A.J., Ojemann, L.M. Interictal, Unifocal Spikes in Refractory Extratemporal Epilepsy Predict Ictal Origin and Post-surgical Outcome. Clinical Neurophysiology 111: 1802-1808, 2000.

67. Holmes, M.D., Wilensky, A.J., Ojemann, L.M., Ojemann, G.A.: Predicting Outcome Following Re-operation for Medically Intractable Epilepsy. Seizure 8:103-106, 1999.

68. Holmes,M.D., Wilensky, A.J., Ojemann, L.M., Ojemann, G.A: Hippocampal or Neocortical Lesions on MRI Do Not Necessarily Indicate Site of Ictal Onsets in Partial Epilepsy. Annals of Neurology 45:461-465, 1999.

69. Iliff JJ, Ngai AC, D’Ambrosio R, and Winn HR. Adenosine receptors mediate glutamate-evoked arteriolar dilation in the rat cerebral cortex. American Journal of Physiology, (2003) 284(5):H1631-1637

70. Johnson MD, Ojemann GA: Role of the human thalamus in language and memory: Evidencefrom electrophysiological studies. Brain and Cognition. 42:218-230, 2000.

71. Kelley WM, Ojemann JG, Wetzel RD, Derdeyn CP, Moran CJ, Cross DT, Dowling JL, MillerJW, Petersen SE. Wada testing reveals lateralization for the memorization of words and faces. Journal of Cognitive Neuroscience, 14:116-125, 2002.

72. Kutsy, RL. Focal extratemporal epilepsy: clinical features, EEG patterns, and surgical approach. J Neurol Sci. 1999 Jun 15;166(1):1-15.

73. Kutsy RL, Farrell DF, Ojemann GA. Ictal patterns of neocortical seizures monitored with intracranial electrodes: correlation with surgical outcome. Epilepsia. 1999 Mar;40(3):257-66.

74. Lemaitre RN, Siscovick DS, Psaty BM, Pearce RM, Raghunathan TE, Whitsel EA, Weinmann SA, Anderson GD, Lin D. Inhaled beta-2 adrenergic receptor agonists and primary cardiac arrest. Am J Med 2002 Dec 15;113(9):711-6

75. Leuthardt EC, Fox D, Ojemann GA, Dacey RG, Grubb RL, Rich KM, Ojemann JG. Frameless stereotaxy without rigid pin fixation during awake craniotomies. Stereotact Funct Neurosurg. 2002;79(3-4):256-61.

76. Lew HL, Dikmen S, Slimp J, Temkin N, Lee EH, Newell D, Robinson LR. Use of somatosensory-evoked potentials and cognitive event-related potentials in predicting outcomes of patients with severe traumatic brain injury. Am J Phys Med Rehabil. 2003 Jan;82(1):53-61; quiz 62-4, 80.

77. LinY-X, Anderson GD, Kantor E, Wilensky AJ, Ojemann LM. Differences in the urinary6-b-hydroxycortisol/cortisol between Asian and Caucasian women. J Clin Pharmacol, 1999;39:578-582.

78 Loring, D. W., Hermann, B. P., Lee, G. P., Drane, D. L., & Meador, K. J. (2000).The Memory Assessment Scales and lateralized temporal lobe epilepsy. The Journal of Clinical Psychology, 56 (4), 563-570.

79. Machamer J, Temkin N, Dikmen S. Significant other burden and factors related to it in traumatic brain injury. J Clin Exp Neuropsych 24(4):420-433,2002.

80. Machamer JE, Temkin NR, Dikmen SS. Neurobehavioral outcome in persons with violent or nonviolent traumatic brain injury. J Head Trauma Rehabil. 2003 Sep-Oct;18(5):387-97.

81. Mathern GW, Pretorius JK, Mendoza D, Leite JP, Chimelli L, Born DE, Fried I, Assirati JA, Ojemann GA, Adelson PD, Cahan LD, Kornblum HI. Hippocampal N-methyl-D-aspartate receptor subunit mRNA levels in temporal lobe epilepsy patients. Ann Neurol. 1999 Sep;46(3):343-58.

82. Mathern GW, Mendoza D, Lozada A, Pretorius JK, Dehnes Y, Danbolt NC, Nelson N, Leite JP, Chimelli L, Born DE, Sakamoto AC, Assirati JA, Fried I, Peacock WJ, Ojemann GA, Adelson PD. Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy. Neurology. 1999 Feb;52(3):453-72.

83. McAuley JW, Anderson GD. Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations. Clin Pharmacokinet 2002;41(8):559-79

84. McKhann II, GM, Schoenfield-McNeill J, Born DE, Ojeman GA: Intraoperative hippocampal electrocorticography to predict the extent of hippocampal resection in temporal lobe epilepsy surgery. J Neurosurg., 93:44-52, 2000.

85. McLaughlin, J., K. Bjornson, N. Temkin, P. Steinbok, V. Wright, A. Reiner, T. Roberts, J.Drake, M. O'Donnell, P. Rosenbaum, J. Barber, and A. Ferrel. Selective dorsal rhizotomy: meta-analysis of three randomized controlled trials. Dev Med Child Neurol, 44(1):17-25, 2002.

86. Mesiwala, AH, Farrell L, Wenzel H J, Crum LA, Silbergeld DL, Winn HR, Mourad PD: High Intensity Focused Ultrasound Selectively Disrupts the Blood-Brain Barrier in vivo. Ultrasound Med & Biol 2002; 28:389-400.

87. Miller JW, Cascino GD, Lagerlund TD, Duntley SP, Westmoreland BF:. Clinical electroencephalographyand related techniques. in Joynt, RJ. (ed.) Clinical Neurology, 2002.

88. Mohutsky M, Anderson GD, Miller JW, Elmer GW. Ginkgo Biloba: Evaluation of drug Interactions in vitro and in vivo, J Clin Pharmacol submitted

89. Narayan RK, Michel ME, Ansell B, Baethmann A, Biegon A, Bracken MB, Bullock MR, Choi SC, Clifton GL, Contant CF, Coplin WM, Dietrich WD, Ghajar J, Grady SM, Grossman RG, Hall ED, Heetderks W, Hovda DA, Jallo J, Katz RL, Knoller N, Kochanek PM,Maas AI, Majde J, Marion DW, Marmarou A, Marshall LF, McIntosh TK, Miller E,Mohberg N, Muizelaar JP, Pitts LH, Quinn P, Riesenfeld G, Robertson CS, Strauss KI, Teasdale G, Temkin N, Tuma R, Wade C, Walker MD, Weinrich M, Whyte J,Wilberger J, Young AB, Yurkewicz L. Clinical trials in head injury. J Neurotrauma 19(5):503-557, 2002.

90. Ngai A.C., Jolley M.A., D’Ambrosio R., Meno J.R. and Winn H.R.: Frequency-dependent changes in cerebral blood flow and evoked potentials during somatosensory stimulation in the rat. BrainResearch (1999), 837:221-228.

91. Nowak SN, Edwards DJ, Clarke A, Anderson GD, Jaber LA. Pioglitazone: effect on CYP3A4 activity. J Clin Pharmacol 2002 Dec;42(12):1299-1302

92. Ojemann GA, Schoenfield-McNeill J: Activityof neurons in human temporal cortex during identification and memory for names and words. J. Neurosci.,19:5674-5682, 1999.

93. Ojemann GA, Schoenfield-McNeill J, Corina DP. Anatomic subdivisions in human temporal cortical neuronal activity related to recent verbal memory. Nat Neurosci. 2002 Jan;5(1):64-71.

94. Ojemann GA: Temporal lobe epilepsy-Current wisdom. Sterotact Funct Neurosurg., 77:213-215, 2002.

95. Ojemann GA: The interplay between neocortical and limbic temporal lobe epilepsy. in Williamson P, Segiel A, Roberts D, Thadani V, Gazzangia M eds., Neocortical Epilepsy. Philadelphia Lippincott-Raven, 2000,615-620.

96. Ojemann GA, Schoenfield-McNeill J, Corina D: Anatomic subdivisions in human temporal cortical neuronal activity related to recent verbal memory. Nature Neurosci., 5:64-71, 2002.

97. Ojemann,L, Dodrill, C., Crawford, C., Holmes M., Dudley D., Ojemann, GA. Language Disturbance as Side Effects of Topirimate and Zonisimide Therapy. Epilepsy & Behavior 2:579-584, 2001.

98. Ojemann JG, Ojemann GA, Lettich E: Cortical stimulation mapping of language cortex by using a verb generation task: effects of learning and comparison to mapping based on objectnaming. J Neurosurg, 97:33-38,2002.

99. Ojemann JG, Ojemann GA, Lettich E. Cortical stimulation mapping of language cortex by using a verb generation task: effects of learning and comparison to mapping based on object naming. J Neurosurg. 2002 Jul;97(1):33-8.

100. Pilcher WH, Ojemann GA: Complication of Epilepsy Surgery, in Post KD, Friedman ED, McCormick P, eds, Post-operative complications in intracranial surgery. New York, Thieme, 1993, 157-165.

101. Poliakov AV, Albright E, Corina D, Ojemann G, Martin RF, Brinkley JF. Server-based approach to web visualization of integrated 3-D medical image data. Proc AMIA Symp. 2001;:533-7

102. Poolos NP: Handbook of Differential Diagnosis in Neurology. Boston: Butterworth-Heinemann, 2001

103. Poolos NP. Das S, Clark GD, Lardizabal D, Noebels JL, Wyllie E, Dobyns WB. Males with epilepsy, complete subcortical band heterotopia, and somatic mosaicism for DCX. Neurology. 2002 May 28;58(10):1559-62.

104. Poolos NP. Migliore M, Johnston D. Pharmacological upregulation of H-channels reduces the excitability of pyramidal neuron dendrites. Nat Neurosci. 2002 Aug;5(8):767-74.

105. Powell J, Temkin NR, Machamer J, Dikmen S. Non-randomized studies of rehabilitation for traumatic brain injury: Can they determine effectiveness? Arch Phys Med Rehabil 83,(9):1235-1244, 2002.

106. Powell J, Temkin NR, Machamer J, Dikmen S. Self-report of extent of recovery and barriers to recovery following traumatic brain injury: a longitudinal study. Arch Phys Med Rehabil 82(8):1025-1030, 2001.

107. Rho JM, Kim DW, Robbins, CA, Anderson GD, Schwartzkroin PA. Age-dependent differences in flurothylseizure sensitivity in mice treated with a ketogenic diet. Epilepsy Research 1999:37;233-240.

108. Rho JM, Anderson GD, Donevan SD, White HS. Acetoacetate, Acetone, and Dibenzylamine (a contaminant inL-(+)-b-Hydroxybutyrate) exhibit direct anticonvulsant actions in vivo, Epilepsia 2002:43:358-361.

109. Roby CA, Anderson GD, Kantor ED, Burstein AH. St John’s Wort: Evaluation of effect on CYP3A4 and 2D6 metabolism. Clin Pharmacol Ther 2000;67:451-7.

110. Salinsky M, Binder LM, Oken BS, Storzbach D, Aron CR, Dodrill, CB. Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers. Epilepsia 2002;43:482-490.

111. Salinsky MC, Storzbach D, Dodrill CB, Binder LM. Test-retest bias, reliability, and regression equations for neuropsychological measures repeated over a 12-16 week period. Journal of the International Neuropsychological Society 2001;7:597-605.

112. Schwartz TH, Haglund MM, Lettich E, Ojemann GA: Asymmetry of neuronal activity during extracellular microelectrode recording from left and right human temporal lobe neocortex during rhyming and line matching. J. Cog. Neurosci,2000, 12:803-812.

113. Servin, J., Sperling, M., Naritoku, D., Schachter, S., Labar, D., Holmes, M., Wilensky,A., Sibula, J., Labiner, D., Bergen, D., Ristanovich, R., Harvey, J., Dasheiff,R., Morris, G., O'Donovan, C., Ojemann, L., Scales, D., Nadkrnim, M., Richards,B., Sanchez, J.: Vagus Nerve Stimulation Therapy for Epilepsy in Older Adults. Neurology 14; 54(5):1179-82, 2000.

114. Silbergeld DL: Controversies in Neurosurgery - Primary Brain Tumors: Resective Surgery Versus Biopsy and Adjuvant Therapy: The Case for Biopsy and Adjuvant Therapy. Clinical Neurosurg 1999; 45:218-220.

115. Siscovick DS, Weinmann SA, Anderson GD, Pearce RM, Lemaitre RN, Whitsel EA, Sotoodehnia N, Rea TD, Psaty BM, Raghunathan TE. Anti-depressants, Anti-psychotics, Anti-convulsants and Primary Cardiac Arrest. Circulation, submitted.

116. Stehman-Breen C, Anderson GD Gipson D, Ott-Ralph S. Pharmacokinetics of Oral Micronized b-Estradiol in Postmenopausal Women with End-Stage Renal Disease. Kidney Internal 2003;64:290-294.

117. Stüve O, Holmes MD, Dodrill CB, Miller JW: The absence of interictal spikes with documented seizures suggests extratemporal epilepsy, Epilepsia, 42:778-781,2001.

118. Sulzbacher S, Farwell JR, Temkin N, Lu AS, Hirtz DG. Late cognitive effects of earlytreatment with phenobarbital. Clin Pediatr (Phila) 38(7):387-394, 1999.

119. Tandon N, Vollmer DG, Ojemann JG, Silbergeld DL: Observations on Overlapping Cortical Simulation Mapping and Pre-Surgical Functional Imaging Data. Human Brain Mapping, In Press

120. Temkin NR. Risk factors for posttraumatic seizures in adults. Epilepsia.2003;44 Suppl 10:18-20.

121. TemkinNR. Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia. 2001 Apr;42(4):515-24.

122. Temkin NR. Prophylactic anticonvulsantsafter neurosurgery. Epilepsy Currents 2(4):1-4, 2002.

123. Temkin NR, Dikmen SS, Anderson GD, Wilensky AJ, Holmes, MD, Newell, DW, Nelson P, Awan AB, Winn HR. Valproate therapy for prevention of post-traumatic seizures: a randomized trial. J Neurological Surgery, 1999;91:593-600

124. Temkin NR, Heaton RK, Grant I, Dikmen SS: Detecting significant change in neuropsychological test performance: A comparison of four models. J Int Neuropsycholy Soc5:357-369, 1999.

125. Temkin NR, Jarell AB, Anderson GD. Antiepileptogenic agents: How close are we? Drugs 2001;61:1045-1055.

126. Temkin NR, Machamer JE, Dikmen SS. Correlates of functional status 3-5 years after traumatic brain injury with CT abnormalities. J Neurotrauma (in press, 2003).

127. Temkin NR. Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: Meta-analysis of controlled trials. Epilepsia 42(4):515-524, 2001.

128. Temkin, N.R., Dikmen, S.S., Anderson, G.D., Wilensky, A.J., Holmes, M.D., Cohen, W., Newel, D.W., Nelson, P., Awan, A., Winn, H.R.: Valproate Therapy for Prevention of Post-Traumatic Seizures:A Randomized Trial. J Neurosurg 91(4):593-600, 1999.

129. Toga A, Ojemann G, Ojemann J, Cannestra A: Intraoperative brain mapping, in Mazziotta J, Toga A, Frackowiak R eds, Brain mapping: the disorders. Academic Press. 2000,77-106.

130. Torack RM, Miller JW, and Roth KA: Deafferentation-induced abnormal neurofilament phosphorylation in red nucleus neurons. Neuropathology and Applied Neurobiology, 27:444-450, 2001.

131. Tralins,KS, Douglas JG, Stelzer KJ, Mankoff, DA, Silbergeld, DL, Rostomily R, Hummel,S, Scharnhorst J, Krohn KA, Spence AM: Volumetric Analysis of 18F-FDG PET in Glioblastoma Multiforme: Prognostic Information and Possible Role in Definition of Target Volumes in Radiation Dose Escalation. J Nucl Med,2002; 43:1667-1673.

132. Vossler DG, Wilensky AJ, Cawthon DF, Kraemer LA, Ojemann LM, Caylor LM, Morgan JD. Serum and CSF glutamine levels in valproate-induced hyperammonemicencephalopathy. Epilepsia 2002; 43:154-159.

133. Watson NF, Doherty MJ, Dodrill CB, Farrell D, Miller JW. The experience of earthquakes by patients with epileptic and psychogenic nonepileptic seizures. Epilepsia 2002;43:317-320.

134. Whyte J, Cifu D, Dikmen S, Temkin N. Prediction of functional outcomes after traumatic brain injury: a comparison of two measures of duration of unconsciousness. Arch Phys Med Rehabil,. 82(10): p. 1355-1359, 2001.